Free Trial

IQVIA (NYSE:IQV) Shares Gap Down - Here's Why

IQVIA logo with Medical background

IQVIA Holdings Inc. (NYSE:IQV - Get Free Report)'s share price gapped down before the market opened on Tuesday . The stock had previously closed at $204.64, but opened at $198.98. IQVIA shares last traded at $199.37, with a volume of 273,028 shares changing hands.

Analyst Upgrades and Downgrades

IQV has been the topic of several recent analyst reports. StockNews.com cut IQVIA from a "buy" rating to a "hold" rating in a research note on Thursday, November 28th. JPMorgan Chase & Co. reduced their target price on IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a research note on Tuesday, November 5th. Evercore ISI dropped their price target on shares of IQVIA from $270.00 to $265.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. William Blair reiterated an "outperform" rating on shares of IQVIA in a research note on Wednesday, December 11th. Finally, Robert W. Baird dropped their target price on shares of IQVIA from $213.00 to $212.00 and set a "neutral" rating for the company in a research report on Wednesday, December 11th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $255.82.

Check Out Our Latest Report on IQVIA

IQVIA Trading Up 0.8 %

The stock has a market capitalization of $35.89 billion, a P/E ratio of 25.95, a price-to-earnings-growth ratio of 2.09 and a beta of 1.48. The business has a 50 day simple moving average of $200.93 and a 200-day simple moving average of $221.44. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of IQV. Private Trust Co. NA boosted its position in shares of IQVIA by 10.7% during the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company's stock valued at $115,000 after purchasing an additional 47 shares in the last quarter. Clear Harbor Asset Management LLC lifted its stake in IQVIA by 1.3% during the third quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company's stock valued at $941,000 after purchasing an additional 50 shares during the last quarter. Pine Valley Investments Ltd Liability Co boosted its holdings in IQVIA by 0.5% during the third quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company's stock worth $2,247,000 after buying an additional 50 shares in the last quarter. Fortitude Family Office LLC increased its holdings in shares of IQVIA by 2.9% in the third quarter. Fortitude Family Office LLC now owns 1,977 shares of the medical research company's stock valued at $468,000 after buying an additional 56 shares in the last quarter. Finally, Huntington National Bank lifted its position in shares of IQVIA by 7.4% during the 3rd quarter. Huntington National Bank now owns 809 shares of the medical research company's stock valued at $192,000 after acquiring an additional 56 shares during the last quarter. Institutional investors own 89.62% of the company's stock.

IQVIA Company Profile

(Get Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Read More

Should You Invest $1,000 in IQVIA Right Now?

Before you consider IQVIA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IQVIA wasn't on the list.

While IQVIA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Analysts boosting their targets. Find out how Oracle’s cloud push is reshaping its business and driving new growth opportunities.

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines